{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:49:04Z","timestamp":1782190144762,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10863-026-10100-6","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:02:30Z","timestamp":1773838950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["METTL16-mediated m6A modification of LYRM2 drives breast cancer progression by inducing CD8+ T cell dysfunction via Glycolysis"],"prefix":"10.1007","volume":"58","author":[{"given":"Mao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaopei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"3","key":"10100_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834From NLM Medline","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10100_CR2","doi-asserted-by":"publisher","first-page":"ITC161","DOI":"10.7326\/AITC202311210","volume":"176","author":"AH Farkas","year":"2023","unstructured":"Farkas AH, Nattinger AB (2023) Breast cancer screening and prevention. Ann Intern Med 176(11):ITC161\u2013ITC176. https:\/\/doi.org\/10.7326\/AITC202311210 IF: 15.2 Q1 B1 From NLM Medline","journal-title":"Ann Intern Med"},{"issue":"1","key":"10100_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5858\/arpa","volume":"147","author":"X Zhang","year":"2023","unstructured":"Zhang X (2023) Molecular classification of breast cancer: relevance and challenges. Arch Pathol Lab Med 147(1):46\u201351. https:\/\/doi.org\/10.5858\/arpa2022-0070-RA From NLM Medline","journal-title":"Arch Pathol Lab Med"},{"key":"10100_CR4","doi-asserted-by":"publisher","unstructured":"Ben-Dror J, Shalamov M, Sonnenblick A (2022) The history of early breast cancer treatment. Genes (Basel) 13(6):960. https:\/\/doi.org\/10.3390\/genes13060960 IF: 2.8 Q2 B3 From NLM Medline","DOI":"10.3390\/genes13060960"},{"key":"10100_CR5","doi-asserted-by":"publisher","first-page":"110709","DOI":"10.1016\/j.biopha.2020.110709","volume":"131","author":"JD Pereira","year":"2020","unstructured":"Pereira JD, Tosatti JAG, Simoes R, Luizon MR, Gomes KB, Alves MT (2020) MicroRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis. Biomed Pharmacother 131:110709. https:\/\/doi.org\/10.1016\/j.biopha.2020.110709From NLM Medline","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10100_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1042\/BST20191055","volume":"48","author":"S Lev","year":"2020","unstructured":"Lev S (2020) Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochem Soc Trans 48(2):657\u2013665. https:\/\/doi.org\/10.1042\/BST20191055 IF: 4.3 Q2 B2 From NLM Medline","journal-title":"Biochem Soc Trans"},{"key":"10100_CR7","doi-asserted-by":"publisher","unstructured":"Dvir K, Giordano S, Leone JP (2024) Immunotherapy in breast cancer. Int J Mol Sci 25(14). https:\/\/doi.org\/10.3390\/ijms25147517From NLM Medline","DOI":"10.3390\/ijms25147517"},{"issue":"18","key":"10100_CR8","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Cancer Res 79(18):4557\u20134566. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3962From NLM Medline","journal-title":"Cancer Res"},{"key":"10100_CR9","doi-asserted-by":"publisher","unstructured":"Hay ZLZ, Slansky JE, Granzymes (2022) The molecular executors of Immune-Mediated cytotoxicity. Int J Mol Sci 23(3). https:\/\/doi.org\/10.3390\/ijms23031833From NLM Medline","DOI":"10.3390\/ijms23031833"},{"key":"10100_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-0716-3754-8_4","volume":"2782","author":"JJ Freen-van Heeren","year":"2024","unstructured":"Freen-van Heeren JJ (2024) Posttranscriptional events orchestrate immune homeostasis of CD8(+) T cells. Methods Mol Biol 2782:65\u201380. https:\/\/doi.org\/10.1007\/978-1-0716-3754-8_4From NLM Medline","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10100_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00262-024-03921-0","volume":"74","author":"F Lu","year":"2025","unstructured":"Lu F, Yan G, Zhao Z, Zheng Z, Wu Y, Wen L, Liu Y, Zeng Q, Zhang G (2025) TDO2\u2009+\u2009cancer-associated fibroblasts mediate cutaneous squamous cell carcinoma immune escape via impeding infiltration of CD8\u2009+\u2009T cells. Cancer Immunol Immunother 74(2):67. https:\/\/doi.org\/10.1007\/s00262-024-03921-0From NLM Medline","journal-title":"Cancer Immunol Immunother"},{"issue":"43","key":"10100_CR12","doi-asserted-by":"publisher","first-page":"e2403629","DOI":"10.1002\/advs.202403629","volume":"11","author":"X Zhou","year":"2024","unstructured":"Zhou X, Chen Z, Yu Y, Li M, Cao Y, Prochownik EV, Li Y (2024) Increases in 4-Acetaminobutyric acid generated by phosphomevalonate kinase suppress CD8(+) T cell activation and allow tumor immune escape. Adv Sci (Weinh) 11(43):e2403629. https:\/\/doi.org\/10.1002\/advs.202403629From NLM Medline","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10100_CR13","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.7150\/ijbs.70137","volume":"18","author":"D Rong","year":"2022","unstructured":"Rong D, Sun G, Zheng Z, Liu L, Chen X, Wu F, Gu Y, Dai Y, Zhong W, Hao X et al (2022) MGP promotes CD8(+) T cell exhaustion by activating the NF-kappaB pathway leading to liver metastasis of colorectal cancer. Int J Biol Sci 18(6):2345\u20132361. https:\/\/doi.org\/10.7150\/ijbs.70137From NLM Medline","journal-title":"Int J Biol Sci"},{"key":"10100_CR14","doi-asserted-by":"publisher","first-page":"216095","DOI":"10.1016\/j.canlet.2023.216095","volume":"558","author":"W Ge","year":"2023","unstructured":"Ge W, Yue M, Lin R, Zhou T, Xu H, Wang Y, Mao T, Li S, Wu X, Zhang X et al (2023) PLA2G2A(+) cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8(+) cytotoxic T cells. Cancer Lett 558:216095. https:\/\/doi.org\/10.1016\/j.canlet.2023.216095From NLM Medline","journal-title":"Cancer Lett"},{"issue":"11","key":"10100_CR15","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/cac2.12605","volume":"44","author":"S Zeng","year":"2024","unstructured":"Zeng S, Hu H, Li Z, Hu Q, Shen R, Li M, Liang Y, Mao Z, Zhang Y, Zhan W et al (2024) Local TSH\/TSHR signaling promotes CD8(+) T cell exhaustion and immune evasion in colorectal carcinoma. Cancer Commun (Lond) 44(11):1287\u20131310. https:\/\/doi.org\/10.1002\/cac2.12605From NLM Medline","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"10100_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-020-01786-6","volume":"40","author":"W Fang","year":"2021","unstructured":"Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H, Zeng Q, Wang Y, Jin F, Chai C et al (2021) Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion. J Exp Clin Cancer Res 40(1):4. https:\/\/doi.org\/10.1186\/s13046-020-01786-6From NLM Medline","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10100_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo M, Tsai CH, Pucino V, Ho PC, Mauro C (2021) Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol 21(3):151\u2013161. https:\/\/doi.org\/10.1038\/s41577-020-0406-2From NLM Medline","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10100_CR18","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","volume":"34","author":"D Guo","year":"2022","unstructured":"Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, Wu Q, Li S, Luo S, Li M et al (2022) Aerobic Glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha. Cell Metab 34(9):1312\u20131324e1316. https:\/\/doi.org\/10.1016\/j.cmet.2022.08.002From NLM Medline","journal-title":"Cell Metab"},{"issue":"1","key":"10100_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1074\/mcp.RA119.001784","volume":"19","author":"MG Dibley","year":"2020","unstructured":"Dibley MG, Formosa LE, Lyu B, Reljic B, McGann D, Muellner-Wong L, Kraus F, Sharpe AJ, Stroud DA, Ryan MT (2020) The mitochondrial Acyl-carrier protein interaction network highlights important roles for LYRM family members in complex I and mitoribosome assembly. Mol Cell Proteom 19(1):65\u201377. https:\/\/doi.org\/10.1074\/mcp.RA119.001784From NLM Medline","journal-title":"Mol Cell Proteom"},{"key":"10100_CR20","doi-asserted-by":"publisher","first-page":"e16104","DOI":"10.7717\/peerj.16104","volume":"11","author":"HY Wang","year":"2023","unstructured":"Wang HY, Xie Y, Du H, Luo B, Li Z (2023) High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration. PeerJ 11:e16104. https:\/\/doi.org\/10.7717\/peerj.16104From NLM Medline","journal-title":"PeerJ"},{"key":"10100_CR21","doi-asserted-by":"publisher","unstructured":"Wang S, Liu JC, Ju Y, Pellecchia G, Voisin V, Wang DY, Leha LR, Ben-David Y, Bader GD, Zacksenhaus E (2017) microRNA-143\/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer. JCI Insight 2(15). https:\/\/doi.org\/10.1172\/jci.insight.93313From NLM PubMed-not-MEDLINE","DOI":"10.1172\/jci.insight.93313"},{"issue":"3","key":"10100_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.21037\/tcr-22-195","volume":"11","author":"S Guo","year":"2022","unstructured":"Guo S, Mao Z, Zhang G, Xu B, He X (2022) CircPTN promotes angiogenesis via the MiR-595\/LYRM5 signaling pathway in non-small cell lung cancer. Transl Cancer Res 11(3):519\u2013529. https:\/\/doi.org\/10.21037\/tcr-22-195From NLM PubMed-not-MEDLINE","journal-title":"Transl Cancer Res"},{"issue":"1","key":"10100_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12935-021-02131-3","volume":"21","author":"Y Pang","year":"2021","unstructured":"Pang Y, Tan G, Yang X, Lin Y, Chen Y, Zhang J, Xie T, Zhou H, Fang J, Zhao Q et al (2021) Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma. Cancer Cell Int 21(1):463. https:\/\/doi.org\/10.1186\/s12935-021-02131-3From NLM PubMed-not-MEDLINE","journal-title":"Cancer Cell Int"},{"key":"10100_CR24","doi-asserted-by":"publisher","first-page":"934830","DOI":"10.3389\/fgene.2022.934830","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Fang T, Lv Y (2022) A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer. Front Genet 13:934830. https:\/\/doi.org\/10.3389\/fgene.2022.934830From NLM PubMed-not-MEDLINE","journal-title":"Front Genet"},{"key":"10100_CR25","unstructured":"Gene expression profiling interactive analysis (2018) http:\/\/gepia2.cancer-pku.cn\/"},{"key":"10100_CR26","unstructured":"Kaplan-Meier (2025) plotter. https:\/\/kmplot.com"},{"key":"10100_CR27","unstructured":"TIMER2 (2020) http:\/\/timer.cistrome.org\/"},{"key":"10100_CR28","unstructured":"RM2Target (2025) http:\/\/rm2target.canceromics.org\/"},{"key":"10100_CR29","unstructured":"Predictors for RNA N6-methyladenosine (m6A) modification site. (2025) http:\/\/www.cuilab.cn\/sramp"},{"issue":"1","key":"10100_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G (2019) Functions of N6-methyladenosine and its role in cancer. Mol Cancer 18(1):176. https:\/\/doi.org\/10.1186\/s12943-019-1109-9From NLM Medline","journal-title":"Mol Cancer"},{"issue":"1","key":"10100_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13046-023-02732-y","volume":"42","author":"W Wei","year":"2023","unstructured":"Wei W, Zhang ZY, Shi B, Cai Y, Zhang HS, Sun CL, Fei YF, Zhong W, Zhang S, Wang C et al (2023) METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression. J Exp Clin Cancer Res 42(1):151. https:\/\/doi.org\/10.1186\/s13046-023-02732-yFrom NLM Medline","journal-title":"J Exp Clin Cancer Res"},{"key":"10100_CR32","doi-asserted-by":"publisher","first-page":"759020","DOI":"10.3389\/fcell.2022.759020","volume":"10","author":"L Lu","year":"2022","unstructured":"Lu L, Zheng D, Qu J, Zhuang Y, Peng J, Lan S, Zhang S, Huang F (2022) METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. Front Cell Dev Biol 10:759020. https:\/\/doi.org\/10.3389\/fcell.2022.759020From NLM PubMed-not-MEDLINE","journal-title":"Front Cell Dev Biol"},{"key":"10100_CR33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2023.12.018","volume":"211","author":"A Shinde","year":"2024","unstructured":"Shinde A, Chandak N, Singh J, Roy M, Mane M, Tang X, Vasiyani H, Currim F, Gohel D, Shukla S et al (2024) TNF-alpha induced NF-kappaB mediated LYRM7 expression modulates the tumor growth and metastatic ability in breast cancer. Free Radic Biol Med 211:158\u2013170. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.12.018From NLM Medline","journal-title":"Free Radic Biol Med"},{"key":"10100_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CMAR.S185205","volume":"11","author":"X Yan","year":"2019","unstructured":"Yan X, Wan H, Hao X, Lan T, Li W, Xu L, Yuan K, Wu H (2019) Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model. Cancer Manag Res 11:273\u2013283 2147\/CMAR.S185205 From NLM PubMed-not-MEDLINE","journal-title":"Cancer Manag Res"},{"key":"10100_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2019.04.021","volume":"455","author":"Q Huang","year":"2019","unstructured":"Huang Q, Chen Z, Cheng P, Jiang Z, Wang Z, Huang Y, Yang C, Pan J, Qiu F, Huang J (2019) LYRM2 directly regulates complex I activity to support tumor growth in colorectal cancer by oxidative phosphorylation. Cancer Lett 455:36\u201347. https:\/\/doi.org\/10.1016\/j.canlet.2019.04.021 From NLM Medline","journal-title":"Cancer Lett"},{"issue":"23","key":"10100_CR36","doi-asserted-by":"publisher","first-page":"e70241","DOI":"10.1111\/jcmm.70241","volume":"28","author":"B Fan","year":"2024","unstructured":"Fan B, Zhang Y, Zhou L, Xie Z, Liu J, Zhang C, Dou C (2024) LYRM2 promotes the growth and metastasis of hepatocellular carcinoma via enhancing HIF-1alpha-Dependent glucose metabolic reprogramming. J Cell Mol Med 28(23):e70241. https:\/\/doi.org\/10.1111\/jcmm.70241From NLM Medline","journal-title":"J Cell Mol Med"},{"issue":"9","key":"10100_CR37","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu L, Jin Y, Zhao X, Tang K, Zhao Y, Tong L, Yu X, Xiong K, Luo C, Zhu J et al (2023) Tumor aerobic Glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-alpha. Cell Metab 35(9):1580\u20131596e1589. https:\/\/doi.org\/10.1016\/j.cmet.2023.07.001From NLM Medline","journal-title":"Cell Metab"},{"issue":"1","key":"10100_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","volume":"18","author":"J Han","year":"2019","unstructured":"Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q et al (2019) METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner. Mol Cancer 18(1):110. https:\/\/doi.org\/10.1186\/s12943-019-1036-9From NLM Medline","journal-title":"Mol Cancer"},{"issue":"7","key":"10100_CR39","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","volume":"48","author":"T Liu","year":"2020","unstructured":"Liu T, Wei Q, Jin J, Luo Q, Liu Y, Yang Y, Cheng C, Li L, Pi J, Si Y et al (2020) The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res 48(7):3816\u20133831. https:\/\/doi.org\/10.1093\/nar\/gkaa048From NLM Medline","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10100_CR40","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1158\/0008-5472.CAN-23-1954","volume":"84","author":"F Shu","year":"2024","unstructured":"Shu F, Liu H, Chen X, Liu Y, Zhou J, Tang L, Cao W, Yang S, Long Y, Li R et al (2024) m6A modification promotes EMT and metastasis of Castration-Resistant prostate cancer by upregulating NFIB. Cancer Res 84(12):1947\u20131962. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-1954From NLM Medline","journal-title":"Cancer Res"},{"issue":"1","key":"10100_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-024-01526-9","volume":"17","author":"M Xue","year":"2024","unstructured":"Xue M, Dong L, Zhang H, Li Y, Qiu K, Zhao Z, Gao M, Han L, Chan AKN, Li W et al (2024) METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation. J Hematol Oncol 17(1):7. https:\/\/doi.org\/10.1186\/s13045-024-01526-9From NLM Medline","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10100_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00018-024-05146-x","volume":"81","author":"Q Li","year":"2024","unstructured":"Li Q, Wang Y, Meng X, Wang W, Duan F, Chen S, Zhang Y, Sheng Z, Gao Y, Zhou L (2024) METTL16 inhibits papillary thyroid cancer tumorigenicity through m(6)A\/YTHDC2\/SCD1-regulated lipid metabolism. Cell Mol Life Sci 81(1):81. https:\/\/doi.org\/10.1007\/s00018-024-05146-xFrom NLM Medline","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10100_CR43","doi-asserted-by":"publisher","first-page":"112150","DOI":"10.1016\/j.celrep.2023.112150","volume":"42","author":"F Wang","year":"2023","unstructured":"Wang F, Zhang J, Lin X, Yang L, Zhou Q, Mi X, Li Q, Wang S, Li D, Liu XM et al (2023) METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2. Cell Rep 42(3):112150. https:\/\/doi.org\/10.1016\/j.celrep.2023.112150From NLM Medline","journal-title":"Cell Rep"},{"issue":"2","key":"10100_CR44","doi-asserted-by":"publisher","first-page":"101776","DOI":"10.1016\/j.aohep.2025.101776","volume":"30","author":"M Chen","year":"2025","unstructured":"Chen M, Yang Y, Hu G, Peng Z, Wen W (2025) The promoting effect of the POU3F2\/METTL16\/PFKM cascade on Glycolysis and tumorigenesis of hepatocellular carcinoma. Ann Hepatol 30(2):101776. https:\/\/doi.org\/10.1016\/j.aohep.2025.101776From NLM Publisher","journal-title":"Ann Hepatol"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10100-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10100-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10100-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:22:25Z","timestamp":1782188545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-026-10100-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10100"],"URL":"https:\/\/doi.org\/10.1007\/s10863-026-10100-6","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Zhuji People\u2019s Hospital, approval number 2024[1227]. Animal experiments were approved by the Guangdong Medical Laboratory Animal Center Animal Ethics Committee and strictly followed the established protocol, approval number D2025-08-2.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"statement\n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patients signed written informed consent.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"31"}}